(Q38748016)

6 September 2017

1 reference

title

Adjuvant systemic therapy: state of the art, 1989. (English)

1 reference

6 September 2017

1 reference

I C Henderson

1

1 reference

PubMed ID

2690970

6 September 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

Breast Cancer Research and Treatment

6 September 2017

1 reference

6 September 2017

14

1 reference

6 September 2017

1

1 reference

6 September 2017

3-22

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01805971

6 September 2017

0 references

cites work

Extended surgical adjuvant thiotepa for mammary carcinoma.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01805971

The Christie hospital adjuvant tamoxifen trial--status at 10 years

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01805971

Dose-response in the treatment of breast cancer: a critical review

21 January 2018

1 reference

12 December 2020

Short- or long-term chemotherapy for node-positive breast cancer: LMF 6 versus 18 cycles. SAKK study 27/76

1 reference

12 December 2020

Adjuvant systemic therapy for early breast cancer

1 reference

12 December 2020

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation

1 reference

12 December 2020

Surgical adjuvant chemotherapy with mitomycin C and cyclophosphamide in Japanese patients with breast cancer

1 reference

12 December 2020

Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy

1 reference

12 December 2020

Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.

1 reference

12 December 2020

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

12 December 2020

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast

1 reference

12 December 2020

Adjuvant endocrine therapy of breast cancer--a controlled clinical trial of oestrogen and anti-oestrogen: preliminary results of the Copenhagen breast cancer trials

1 reference

12 December 2020

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

12 December 2020

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

12 December 2020

Editorial: Major advance in breast-cancer therapy

1 reference

12 December 2020

Clinical trials on adjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status

1 reference

12 December 2020

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

1 reference

12 December 2020

Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy

1 reference

12 December 2020

Patterns of relapse and survival in operable breast carcinoma with positive and negative axillary nodes

1 reference

12 December 2020

Adjuvant therapy in node-negative breast cancer. A panel discussion

1 reference

12 December 2020

Breast cancer therapy: exercising all our options

1 reference

12 December 2020

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

12 December 2020

Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party

1 reference

12 December 2020

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons

1 reference

12 December 2020

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

12 December 2020

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer

1 reference

12 December 2020

The concept of an overview of cancer clinical trials with special emphasis on early breast cancer.

1 reference

12 December 2020

A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.

1 reference

12 December 2020

Radical versus modified radical mastectomy for breast cancer

1 reference

12 December 2020

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

12 December 2020

Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience

1 reference

12 December 2020

Adjuvant therapy of breast cancer: Southwest Oncology Group studies

1 reference

12 December 2020

Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle

1 reference

12 December 2020

Duration of therapy in adjuvant chemotherapy trials

1 reference

12 December 2020

Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01805971

1 reference

PubMed ID

2690970

Dimensions Publication ID

6 September 2017

0 references

1 reference

PubMed ID

2690970